FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 320:1574-1580 June 15, 1989 Number 24 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Congenital agranulocytosis is a disorder characterized by severe neutropenia and a profound deficiency of identifiable neutrophil progenitors in bone marrow. In an attempt to stimulate neutrophil production and thereby reduce the morbidity and mortality associated with this disease, we administered recombinant human granulocyte colony-stimulating factor (rhG-CSF) in doses of 3 to 60 micrograms per kilogram of body weight per day to five patients with congenital agranulocytosis. In all five patients, an increase in the number of neutrophils was noted eight to nine days after the initiation of the effective dosage (the dose at which the neutrophil count reached 1000 cells per microliter or more and the bone marrow showed granulocyte maturation beyond the myelocyte stage). The absolute neutrophil counts rose from less than 100 to between 1300 and 9500 cells per microliter. Marrow aspirates obtained after 14 days at the effective dosage showed maturation to the mature neutrophil stage. The side effects that were observed were medullary pain, splenomegaly, and an elevation of levels of leukocyte alkaline phosphatase. All five patients have had sustained neutrophil counts of 1000 cells per microliter or more for 9 to 13 months while receiving subcutaneous maintenance therapy. Preexisting chronic infections have resolved clinically, and the number of new infectious episodes and the requirement for intravenous antibiotics have decreased. We conclude that treatment with rhG-CSF can lead to a large increase in the numbers of functional neutrophils in patients with congenital agranulocytosis.

Source Information

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

This article has been cited by other articles:

• Boztug, K., Appaswamy, G., Ashikov, A., Schaffer, A. A., Salzer, U., Diestelhorst, J., Germeshausen, M., Brandes, G., Lee-Gossler, J., Noyan, F., Gatzke, A.-K., Minkov, M., Greil, J., Kratz, C., Petropoulou, T., Pellier, I., Bellanne-Chantelot, C., Rezaei, N., Monkemoller, K., Irani-Hakimeh, N., Bakker, H., Gerardy-Schahn, R., Zeidler, C., Grimbacher, B., Welte, K., Klein, C. (2009). A Syndrome with Congenital Neutropenia and Mutations in G6PC3. NEJM 360: 32-43 [Abstract] [Full Text]  
• Hershman, D., Neugut, A. I., Jacobson, J. S., Wang, J., Tsai, W.-Y., McBride, R., Bennett, C. L., Grann, V. R. (2007). Acute Myeloid Leukemia or Myelodysplastic Syndrome Following Use of Granulocyte Colony-Stimulating Factors During Breast Cancer Adjuvant Chemotherapy. JNCI J Natl Cancer Inst 99: 196-205 [Abstract] [Full Text]  
• Germeshausen, M., Ballmaier, M., Welte, K. (2007). Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood 109: 93-99 [Abstract] [Full Text]  
• James, R M, Kinsey, S E (2006). The investigation and management of chronic neutropenia in children. Arch. Dis. Child. 91: 852-858 [Abstract] [Full Text]  
• Ermis, B., Yaman, Y., Taspinar, O. (2005). Index of suspicion in the nursery. NeoReviews 6: e241-e243 [Full Text]  
• Kuramoto, K., Follmann, D. A., Hematti, P., Sellers, S., Agricola, B. A., Metzger, M. E., Donahue, R. E., von Kalle, C., Dunbar, C. E. (2004). Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates. Blood 103: 4070-4077 [Abstract] [Full Text]  
• Kawaguchi, H., Kobayashi, M., Nakamura, K., Konishi, N., Miyagawa, S.-i., Sato, T., Toyoda, H., Komada, Y., Kojima, S., Todoroki, Y., Ueda, K., Katoh, O. (2003). Dysregulation of transcriptions in primary granule constituents during myeloid proliferation and differentiation in patients with severe congenital neutropenia. J. Leukoc. Biol. 73: 225-234 [Abstract] [Full Text]  
• Lakshman, R, Finn, A (2001). Neutrophil disorders and their management. J. Clin. Pathol. 54: 7-19 [Abstract] [Full Text]  
• Nakamura, K., Kobayashi, M., Konishi, N., Kawaguchi, H., Miyagawa, S.-i., Sato, T., Toyoda, H., Komada, Y., Kojima, S., Katoh, O., Ueda, K. (2000). Abnormalities of primitive myeloid progenitor cells expressing granulocyte colony-stimulating factor receptor in patients with severe congenital neutropenia. Blood 96: 4366-4369 [Abstract] [Full Text]  
• Jeha, S., Chan, K. W., Aprikyan, A. G., Hoots, W. K., Culbert, S., Zietz, H., Dale, D. C., Albitar, M. (2000). Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia. Blood 96: 3647-3649 [Abstract] [Full Text]  
• Dale, D. C., Person, R. E., Bolyard, A. A., Aprikyan, A. G., Bos, C., Bonilla, M. A., Boxer, L. A., Kannourakis, G., Zeidler, C., Welte, K., Benson, K. F., Horwitz, M. (2000). Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96: 2317-2322 [Abstract] [Full Text]  
• Tefferi, A., Elliott, M. A., Kao, P. C., Yoon, S., El-Hemaidi, I., Pearson, T. C. (2000). Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera. Blood 96: 1582-1584 [Abstract] [Full Text]  
• Zeidler, C., Welte, K., Barak, Y., Barriga, F., Bolyard, A. A., Boxer, L., Cornu, G., Cowan, M. J., Dale, D. C., Flood, T., Freedman, M., Gadner, H., Mandel, H., O'Reilly, R. J., Ramenghi, U., Reiter, A., Skinner, R., Vermylen, C., Levine, J. E. (2000). Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 95: 1195-1198 [Abstract] [Full Text]  
• Calhoun, D. A., Lunøe, M., Du, Y., Hutson, A. D., Veerman, M., Christensen, R. D. (2000). Granulocyte Colony-Stimulating Factor Serum and Urine Concentrations in Neutropenic Neonates Before and After Intravenous Administration of Recombinant Granulocyte Colony-Stimulating Factor. Pediatrics 105: 392-397 [Abstract] [Full Text]  
• Dinauer, M. C., Lekstrom-Himes, J. A., Dale, D. C. (2000). Inherited Neutrophil Disorders: Molecular Basis and New Therapies. ASH Education Book 2000: 303-318 [Abstract] [Full Text]  
• Konishi, N., Kobayashi, M., Miyagawa, S.-i., Sato, T., Katoh, O., Ueda, K. (1999). Defective Proliferation of Primitive Myeloid Progenitor Cells in Patients With Severe Congenital Neutropenia. Blood 94: 4077-4083 [Abstract] [Full Text]  
• Sreenan, C., Osiovich, H. (1999). Myeloid Colony-Stimulating Factors: Use in the Newborn. Arch Pediatr Adolesc Med 153: 984-988 [Abstract] [Full Text]  
• Ward, A. C., van Aesch, Y. M., Gits, J., Schelen, A. M., de Koning, J. P., van Leeuwen, D., Freedman, M. H., Touw, I. P. (1999). Novel Point Mutation in the Extracellular Domain of the Granulocyte Colony-stimulating Factor (G-CSF) Receptor in a Case of Severe Congenital Neutropenia Hyporesponsive to G-CSF Treatment. JEM 190: 497-508 [Abstract] [Full Text]  
• Hunter, M. G., Avalos, B. R. (1999). Deletion of a Critical Internalization Domain in the G-CSFR in Acute Myelogenous Leukemia Preceded by Severe Congenital Neutropenia. Blood 93: 440-446 [Abstract] [Full Text]  
• Haurie, C., Dale, D. C., Mackey, M. C. (1998). Cyclical Neutropenia and Other Periodic Hematological Disorders: A Review of Mechanisms and Mathematical Models. Blood 92: 2629-2640 [Abstract] [Full Text]  
• Tidow, N., Pilz, C., Teichmann, B., Muller-Brechlin, A., Germeshausen, M., Kasper, B., Rauprich, P., Sykora, K.-W., Welte, K. (1997). Clinical Relevance of Point Mutations in the Cytoplasmic Domain of the Granulocyte Colony-Stimulating Factor Receptor Gene in Patients With Severe Congenital Neutropenia. Blood 89: 2369-2375 [Abstract] [Full Text]  
• Calhoun, D. A., Christensen, R. D. (1997). The Occurrence of Kostmann Syndrome in Preterm Neonates. Pediatrics 99: 259-259 [Full Text]  
• Dong, F., Brynes, R. K., Tidow, N., Welte, K., Lowenberg, B., Touw, I. P. (1995). Mutations in the Gene for the Granulocyte Colony-Stimulating-Factor Receptor in Patients with Acute Myeloid Leukemia Preceded by Severe Congenital Neutropenia. NEJM 333: 487-493 [Abstract] [Full Text]  
• Souid, A. K. (1995). Congenital Cyclic Neutropenia. CLIN PEDIATR 34: 151-155  
• Dunkel, I. J., Bussel, J. B. (1993). New Developments in the Treatment of Neutropenia. Arch Pediatr Adolesc Med 147: 994-1000 [Abstract]  
• Weinberger, M., Hollingsworth, H., Feuerstein, I. M., Young, N. S., Pizzo, P. A. (1993). Successful Surgical Management of Neutropenic Enterocolitis in Two Patients With Severe Aplastic Anemia: Case Reports and Review of the Literature. Arch Intern Med 153: 107-113 [Abstract]  
• Baue, A. E. (1992). The Horror Autotoxicus and Multiple-Organ Failure. Arch Surg 127: 1451-1462 [Abstract]  
• Metcalf, D (1991). Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science 254: 529-533 [Abstract]  
• Glasser, L., Duncan, B. R., Corrigan, J. J. Jr (1991). Measurement of Serum Granulocyte Colony-Stimulating Factor in a Patient With Congenital Agranulocytosis (Kostmann's Syndrome). Arch Pediatr Adolesc Med 145: 925-928 [Abstract]  
• Roberts, R. L., Szelc, C. M., Scates, S. M., Boyd, M. T., Soderstrom, K. M., Davis, M. W., Glaspy, J. A. (1991). Neutropenia in an Extremely Premature Infant Treated With Recombinant Human Granulocyte Colony-Stimulating Factor. Arch Pediatr Adolesc Med 145: 804-807 [Abstract]  
• Jonsson, O. G., Buchanan, G. R. (1991). Chronic Neutropenia During Childhood: A 13-Year Experience in a Single Institution. Arch Pediatr Adolesc Med 145: 232-235 [Abstract]  
• Lindley, C. M., Gordon, T. R. (1991). Application of Biotechnology Products in Oncology. Journal of Pharmacy Practice 4: 117-130  
• Hong, R. (1990). Update on the Immunodeficiency Diseases. Arch Pediatr Adolesc Med 144: 983-992 [Abstract]